Trial intelligence / Profile preview

Pharmacokinetic Evaluation of Sublingual Versus Oral Tacrolimus in Kidney Transplant Candidates

NCT00629122Phase 4Completed

Sponsor
Weill Cornell Medicine
Start
Feb 2008
Primary completion
Dec 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of tacrolimus + Wuzhi capsule in chronic kidney disease (CKD), sponsored by Weill Cornell Medicine. Started Feb 2008; status: completed.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT00629122.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00629122.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call